Sleep optimization to improve glycemic control in adults with type 1 diabetes: study protocol for a randomized controlled parallel intervention trial

Pamela Martyn-Nemeth, Jennifer Duffecy, Laurie Quinn, Sirimon Reutrakul, Alana D Steffen, Larisa Burke, Margaret H Clark Withington, Ghada Abu Irsheed, Rose Perez, Minsun Park, Adam Saleh, Dan Mihailescu, Kelly Glazer Baron, Pamela Martyn-Nemeth, Jennifer Duffecy, Laurie Quinn, Sirimon Reutrakul, Alana D Steffen, Larisa Burke, Margaret H Clark Withington, Ghada Abu Irsheed, Rose Perez, Minsun Park, Adam Saleh, Dan Mihailescu, Kelly Glazer Baron

Abstract

Background: Despite improvements in treatment regimens and technology, less than 20% of adults with type 1 diabetes (T1D) achieve glycemic targets. Sleep is increasingly recognized as a potentially modifiable target for improving glycemic control. Diabetes distress, poor self-management behaviors, and reduced quality of life have also been linked to sleep variability and insufficient sleep duration. A significant gap of knowledge exists regarding interventions to improve sleep and the effects of sleep optimization on glycemic control in T1D. The purpose of this study is to determine the efficacy of a T1D-specific sleep optimization intervention (Sleep-Opt) on the primary outcomes of sleep variability, sleep duration, and glycemic control (A1C); other glycemic parameters (glycemic variability, time-in-range [TIR]); diabetes distress; self-management behaviors; quality of life; and other patient-reported outcomes in adults with T1D and habitual increased sleep variability or short sleep duration.

Methods: A randomized controlled parallel-arm study will be employed in 120 adults (aged 18 to 65 years) with T1D. Participants will be screened for habitual sleep variability (> 1 h/week) or insufficient sleep duration (< 6.5 h per night). Eligible subjects will be randomized to the Sleep-Opt intervention group or healthy living attention control group for 12 weeks. A 1-week run-in period is planned, with baseline measures of sleep by actigraphy (sleep variability and duration), glycemia (A1C and related glycemic measures: glycemic variability and TIR using continuous glucose monitoring), and other secondary outcomes: diabetes distress, self-management behaviors, quality of life, and additional patient-reported outcomes. Sleep-Opt is a technology-assisted behavioral sleep intervention that we recently developed that leverages the rapidly increasing public interest in sleep tracking. Our behavioral intervention employs four elements: a wearable sleep tracker, didactic content, an interactive smartphone application, and brief telephone counseling. The attention control group will participate in a healthy living information program. Baseline measures will be repeated at midpoint, program completion, and post-program (weeks 6, 12, and 24, respectively) to determine differences between the two groups and sustainability of the intervention.

Discussion: A better understanding of strategies to improve sleep in persons with T1D has the potential to be an important component of diabetes.

Trial registration: Clinical Trial Registration: NCT04506151 .

Keywords: Glycemic control; Glycemic variability; Randomized controlled trial; Sleep; Type 1 diabetes.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Model of relationships among sleep, glycemic control, distress, self-management behavior and QoL

References

    1. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin elvels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;1441:846–850.
    1. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller AA, Penev PD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr. 2009;89:126–133.
    1. Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014;1311:151–173.
    1. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626.
    1. Klingenberg L, Chaput JP, Holmback U, Visby T, Jennum P, Nikolic M, et al. Acute sleep restriction reduces insulin sensitivity in adolescent boys. Sleep. 2013;36(7):1085–1090.
    1. Okun ML, Reynolds CF, 3rd, Buysse DJ, Monk TH, Mazumdar S, Begley A, et al. Sleep variability, health-related practices, and inflammatory markers in a community dwelling sample of older adults. Psychosom Med. 2011;73(2):142–150.
    1. Huang T, Redline S. Cross-sectional and prospective associations of actigraphy-assessed sleep regularity with metabolic abnormalities: the multi-ethnic study of atherosclerosis. Diabetes Care. 2019;42(8):1422–1429.
    1. Zhu Y, Li AM, Au CT, Kong AP, Zhang J, Wong CK, et al. Association between sleep architecture and glucose tolerance in children and adolescents. J Diabetes. 2015;7(1):10–15.
    1. Meerlo P, Havekes R, Steiger A. Chronically restricted or disrupted sleep as a causal factor in the development of depression. Curr Top Behav Neurosci. 2015;25:459–481.
    1. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–1492.
    1. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33(9):1159–1164.
    1. Kripke DF, Langer RD, Elliott JA, Klauber MR, Rex KM. Mortality related to actigraphic long and short sleep. Sleep Med. 2011;12(1):28–33.
    1. Owens J. Insufficient sleep in adolescents and young adults: an update on causes and consequences. Pediatrics. 2014;134(3):e921–e932.
    1. Winzeler K, Voellmin A, Schafer V, Meyer AH, Cajochen C, Wilhelm FH, et al. Daily stress, presleep arousal, and sleep in healthy young women: a daily life computerized sleep diary and actigraphy study. Sleep Med. 2014;15(3):359–366.
    1. Nefs G, Donga E, van Someren E, Bot M, Speight J, Pouwer F. Subjective sleep impairment in adults with type 1 or type 2 diabetes: Results from Diabetes MILES--The Netherlands. Diabetes Res Clin Pract. 2015;109(3):466–475.
    1. Reutrakul S, Thakkinstian A, Anothaisintawee T, Chontong S, Borel AL, Perfect MM, et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23:26–45.
    1. Chontong S, Saetung S, Reutrakul S. Higher sleep variability is associated with poorer glycaemic control in patients with type 1 diabetes. J Sleep Res. 2016;25(4):438–444.
    1. Estrada CL, Danielson KK, Drum ML, Lipton RB. Insufficient sleep in young patients with diabetes and their families. Biol Res Nurs. 2012;14(1):48–54.
    1. Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PLoS One. 2013;8(9):e74195.
    1. Matejko B, Kiec-Wilk B, Szopa M, Morawska IT, Malecki MT, Klupa T. Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps? J Diabetes Invest. 2015;6(4):460–464.
    1. Denic-Roberts H, Costacou T, Orchard TJ. Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: The Pittsburgh's Epidemiology of Diabetes Complications study. Diabetes Res Clin Pract. 2016;119:1–12.
    1. Borel AL, Pepin JL, Nasse L, Baguet JP, Netter S, Benhamou PY. Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes. Diabetes Care. 2013;36(10):2902–2908.
    1. van Dijk M, Donga E, van Dijk JG, Lammers GJ, van Kralingen KW, Dekkers OM, et al. Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus. Diabetologia. 2011;54(8):1967–1976.
    1. Bachle C, Lange K, Stahl-Pehe A, Castillo K, Holl RW, Giani G, et al. Associations between HbA1c and depressive symptoms in young adults with early-onset type 1 diabetes. Psychoneuroendocrinology. 2015;55:48–58.
    1. Jaser SS, Foster NC, Nelson BA, Kittelsrud JM, DiMeglio LA, Quinn M, et al. Sleep in children with type 1 diabetes and their parents in the T1D Exchange. Sleep Med. 2017;39:108–115.
    1. Donga E, van Dijk M, van Dijk JG, Biermasz NR, Lammers GJ, Van Kralingen K, et al. Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care. 2010;33(7):1573–1577.
    1. Martyn-Nemeth P, Quinn L, Park C, Reutrakul S. Objectively measured sleep variability is associated with glucose, diabetes distress and fear of hypoglycemia in adults with type 1 diabetes. Advanced Technologies & Treatments for Diabetes. Berlin: Diabetes Technology and Therapeutics; 2019. p. ATTD19-0301; 2019.
    1. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106(11):4453–4458.
    1. Leproult R, Holmback U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014;63(6):1860–1869.
    1. Patel NJ, Savin KL, Kahanda SN, Malow BA, Williams LA, Lochbihler G, et al. Sleep habits in adolescents with type 1 diabetes: variability in sleep duration linked with glycemic control. Pediatr Diabetes. 2018;19:1100–6.
    1. Larcher S, Gauchez AS, Lablanche S, Pepin JL, Benhamou PY, Borel AL. Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag. Eur J Endocrinol. 2016;175(5):411–419.
    1. von Schnurbein J, Boettcher C, Brandt S, Karges B, Dunstheimer D, Galler A, et al. Sleep and glycemic control in adolescents with type 1 diabetes. Pediatr Diabetes. 2018;19(1):143–149.
    1. Virk SA, Donaghue KC, Cho YH, Benitez-Aguirre P, Hing S, Pryke A, et al. Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes. J Clin Endocrinol Metabol. 2016;101(9):3257–3263.
    1. Yoon JE, Sunwoo JS, Kim JS, Roh H, Ahn MY, Woo HY, et al. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients. J Diabetes Complications. 2017;31(2):390–394.
    1. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336–347.
    1. Bell KJ, Barclay AW, Petocz P, Colagiuri S, Brand-Miller JC. Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2014;2(2):133–140.
    1. Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S46–s59.
    1. Jaser SS, Bergner EM, Hamburger ER, Bhatia S, Lyttle M, Bell GE, et al. Pilot trial of a sleep-promoting intervention for children with type 1 diabetes. J Pediatr Psychol. 2021;46(3):304–313.
    1. Jaser SS, Hamburger ER, Bergner EM, Williams R, Slaughter JC, Simmons JH, et al. Sleep coach intervention for teens with type 1 diabetes: Randomized pilot study. Pediatr Diabetes. 2020;21(3):473–478.
    1. Perfect MM, Beebe D, Levine-Donnerstein D, Frye SS, Bluez GP, Quan SF. The development of a clinically relevant sleep modification protocol for youth with type 1 diabetes. Clin Pract Pediatr Psychol. 2016;4(2):227–240.
    1. Perfect MM, Frye SS, Bluez GP. The effects of a sleep extension intervention on glucose control in youth with type 1 diabetes. Diabetes. 2018;67(Supplement_1).
    1. Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res. 2014;77(3):174–179.
    1. Sturt J, Dennick K, Due-Christensen M, McCarthy K. The detection and management of diabetes distress in people with type 1 diabetes. Curr Diab Rep. 2015;15(11):101.
    1. Martyn-Nemeth P, Phillips SA, Mihailescu D, Farabi SS, Park C, Lipton R, et al. Poor sleep quality is associated with nocturnal glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetes. J Adv Nurs. 2018;74(10):2373–2380.
    1. Hessler DM, Fisher L, Polonsky WH, Masharani U, Strycker LA, P. Diabetes distress is linked with worsening diabetes management over time in adults with Type 1 diabetes. Diabetic Med. 2017;34(9):1228–1234.
    1. Martyn-Nemeth P, Quinn L, Hacker E, Park H, Kujath AS. Diabetes distress may adversely affect the eating styles of women with type 1 diabetes. Acta Diabetol. 2014;51(4):683–686.
    1. Perfect MM, Patel PG, Scott RE, Wheeler MD, Patel C, Griffin K, et al. Sleep, glucose, and daytime functioning in youth with type 1 diabetes. Sleep. 2012;35(1):81–88.
    1. Fisher L, Hessler D, Polonsky W, Strycker L, Masharani U, Peters A. Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. J Diabetes Complications. 2016;30(6):1123–1128.
    1. Martyn-Nemeth P, Schwarz Farabi S, Mihailescu D, Nemeth J, Quinn L. Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review. J Diabetes Complications. 2016;30(1):167–177.
    1. McDonough RJ, Clements MA, DeLurgio SA, Patton SR. Sleep duration and its impact on adherence in adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2017;18(4):262–270.
    1. Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196–205.
    1. Titov N, Andrews G, Davies M, McIntyre K, Robinson E, Solley K. Internet treatment for depression: a randomized controlled trial comparing clinician vs. technician assistance. PLoS One. 2010;5(6):e10939.
    1. Mohr DC, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. J Med Internet Res. 2011;13(1):e30.
    1. Lerner JS, Tetlock PE. Accounting for the effects of accountability. Psychol Bull. 1999;125(2):255–275.
    1. Tyler TR. The psychology of legitimacy: a relational perspective on voluntary deference to authorities. Pers Soc Psychol Rev. 1997;1(4):323–345.
    1. Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–668.
    1. Miller WR, Rollnick S. Motivational interviewing: prepairing people for change. 2. New York: Guildford Press; 2002.
    1. Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–608.
    1. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485–491.
    1. Meltzer LJ, Hiruma LS, Avis K, Montgomery-Downs H, Valentin J. Comparison of a commercial accelerometer with polysomnography and actigraphy in children and adolescents. Sleep. 2015;38(8):1323–1330.
    1. Montgomery-Downs HE, Insana SP, Bond JA. Movement toward a novel activity monitoring device. Sleep Breath. 2012;16(3):913–917.
    1. Marino M, Li Y, Rueschman MN, Winkelman JW, Ellenbogen JM, Solet JM, et al. Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography. Sleep. 2013;36(11):1747–1755.
    1. Clark, et al. Reduced Awareness of Hypoglycemia in Adults with IDDM. Diab Care. 1995;18(4):517–22.
    1. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (New York, NY) 2012;19(4):387–395.
    1. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) Diabetes Technol Ther. 2013;15(3):198–211.
    1. Rodbard D. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther. 2009;11(9):551–565.
    1. Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015;29(4):572–577.
    1. Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013;11:138.
    1. DCCT Research Group Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988;11(9):725–732.
    1. Cella D, Lai JS, Jensen SE, Christodoulou C, Junghaenel DU, Reeve BB, et al. PROMIS Fatigue Item Bank had clinical validity across diverse chronic conditions. J Clin Epidemiol. 2016;73:128–134.
    1. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1:385–401.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
    1. Lorig K. Self-Efficacy for Diabetes: Stanford University; Available from . Accessed 10 Aug 2022.
    1. Jordan P, Shedden-Mora MC, Lowe B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PLoS One. 2017;12(8):e0182162.
    1. Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, et al. Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes. Diabetes Care. 2011;34(4):801–806.
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545.
    1. Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17(11):787–794.
    1. Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2015;17(3):177–186.
    1. Patel SR, Weng J, Rueschman M, Dudley KA, Loredo JS, Mossavar-Rahmani Y, et al. Reproducibility of a standardized actigraphy scoring algorithm for sleep in a US Hispanic/Latino population. Sleep. 2015;38(9):1497–1503.
    1. Ritter PL, Lorig K, Laurent DD. Characteristics of the Spanish- and English-language self-efficacy to manage diabetes scales. Diabetes Educ. 2016;42(2):167–177.
    1. Rosner B. Fundamentals of biostatistics. 7th ed. Boston: Brooks/Cole; 2011.
    1. Hedeker D, Gibbons RD. Longitudinal data analysis: Wiley-Interscience; 2006.
    1. Mallinckrod CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Inf J. 2008;42(4):303–319.
    1. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach: Guilford publications; 2017.
    1. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549–576.
    1. Enders CK. Applied missing data analysis: Guilford press; 2010.
    1. Mohr DC, Duffecy J, Ho J, Kwasny M, Cai X, Burns MN, et al. A randomized controlled trial evaluating a manualized TeleCoaching protocol for improving adherence to a web-based intervention for the treatment of depression. PLoS One. 2013;8(8):e70086.
    1. Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66–72.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj